BioCentury | Jul 15, 2019
Company News

Management tracks: GSK, Orphazyme, Kymera and more

...The protein degradation company also hired Bruce Jacobs as CFO. Jacobs was managing partner at Westfield Capital...
BioCentury | Sep 15, 2008
Finance

Ebb & Flow

...hematologic malignancies and solid tumors. New investor Nomura Phase4 led the round. Another new investor, Westfield Capital...
BioCentury | Sep 9, 2008
Financial News

Proteolix raises $79 million

...$79 million in a series C round led by new investor Nomura Phase4. New investor Westfield Capital...
BioCentury | Jul 16, 2008
Financial News

Collegium raises $20 million

...a series D round led by Frazier Healthcare Ventures. Existing investors Boston Millennia Partners and Westfield Capital...
BioCentury | May 26, 2008
Finance

Ebb & Flow

...with the neurology diagnostics products business of Medtronic (NYSE:MDT). Private equity tracks Lawrence Fritz joined Westfield Capital...
BioCentury | May 1, 2008
Financial News

Concert raises $37 million

...investor. Other participants were new investors Adage Capital Management; SR One; Mediphase Venture Partners; and Westfield Capital...
BioCentury | Mar 24, 1997
Emerging Company Profile

Ontogeny Inc.

...Liberty; Charles River; Medical Science Partners; Mehta & Isaly; New York Life; Invesco; Vulcan Ventures; Westfield Capital...
Items per page:
1 - 7 of 7
BioCentury | Jul 15, 2019
Company News

Management tracks: GSK, Orphazyme, Kymera and more

...The protein degradation company also hired Bruce Jacobs as CFO. Jacobs was managing partner at Westfield Capital...
BioCentury | Sep 15, 2008
Finance

Ebb & Flow

...hematologic malignancies and solid tumors. New investor Nomura Phase4 led the round. Another new investor, Westfield Capital...
BioCentury | Sep 9, 2008
Financial News

Proteolix raises $79 million

...$79 million in a series C round led by new investor Nomura Phase4. New investor Westfield Capital...
BioCentury | Jul 16, 2008
Financial News

Collegium raises $20 million

...a series D round led by Frazier Healthcare Ventures. Existing investors Boston Millennia Partners and Westfield Capital...
BioCentury | May 26, 2008
Finance

Ebb & Flow

...with the neurology diagnostics products business of Medtronic (NYSE:MDT). Private equity tracks Lawrence Fritz joined Westfield Capital...
BioCentury | May 1, 2008
Financial News

Concert raises $37 million

...investor. Other participants were new investors Adage Capital Management; SR One; Mediphase Venture Partners; and Westfield Capital...
BioCentury | Mar 24, 1997
Emerging Company Profile

Ontogeny Inc.

...Liberty; Charles River; Medical Science Partners; Mehta & Isaly; New York Life; Invesco; Vulcan Ventures; Westfield Capital...
Items per page:
1 - 7 of 7